Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

8.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
8.0K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

745
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
745
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

621
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
621

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

JAMA·2026
Same author

Stage-specific regional distribution of amyloid and tau deposition across the Alzheimer's disease continuum revealed by tau-to-amyloid ratio imaging.

European journal of nuclear medicine and molecular imaging·2026
Same author

Interaction of moderate-to-vigorous physical activity and brain amyloid accumulation on longitudinal cognitive change.

GeroScience·2026
Same author

Daily intake of cuminaldehyde-rich cumin essential oil improves cognitive function in healthy elderly Japanese adults: a randomized, double-blind, placebo-controlled pilot study.

Frontiers in nutrition·2026
Same author

Occurrence of healthcare-associated infections caused by the zoonotic bacterium Pasteurella multocida subsp. gallicida in patients with severe motor and intellectual disabilities in Japan.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same author

Prolonged morning wake transitions associated with amyloid beta burden: A cross-sectional pilot study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Related Experiment Video

Updated: Mar 25, 2026

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
09:58

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury

Published on: November 9, 2018

8.1K

Brain fluorodeoxyglucose (FDG) PET in dementia.

Takashi Kato1, Yoshitaka Inui2, Akinori Nakamura3

  • 1Department of Radiology, National Center for Geriatrics and Gerontology, Japan; Department of Clinical and Experimental Neuroimaging, National Center for Geriatrics and Gerontology, Japan.

Ageing Research Reviews
|February 16, 2016
PubMed
Summary

Fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging helps identify dementia types by visualizing neural injury patterns. FDG PET can distinguish Alzheimer's disease, Lewy body dementia, and frontotemporal dementia, aiding in diagnosis and predicting cognitive decline.

Keywords:
Alzheimer's diseaseDementiaFDG PETFluorodeoxyglucoseMild cognitive impairmentPreclinical AD

More Related Videos

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.1K
Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
09:03

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Published on: October 22, 2019

11.1K

Related Experiment Videos

Last Updated: Mar 25, 2026

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
09:58

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury

Published on: November 9, 2018

8.1K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.1K
Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
09:03

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Published on: October 22, 2019

11.1K

Area of Science:

  • Neuroimaging
  • Nuclear Medicine
  • Neurology

Background:

  • Dementia diagnosis relies on identifying patterns of neural injury and synaptic dysfunction.
  • Fluorodeoxyglucose (FDG) positron emission tomography (PET) visualizes metabolic activity, serving as a marker for brain function.

Purpose of the Study:

  • To provide a concise summary of FDG PET's role in dementia imaging.
  • To highlight FDG PET's ability to identify distinct dementia phenotypes.

Main Methods:

  • Utilizing FDG PET to visualize topographical patterns of neural injury and synaptic dysfunction.
  • Analyzing metabolic hypometabolism in specific brain regions associated with different dementias.
  • Employing voxel-based statistical analyses like SPM and 3D SSP to enhance diagnostic performance.

Main Results:

  • Alzheimer's disease dementia exhibits hypometabolism in parietotemporal, posterior cingulate, and precuneus areas.
  • Hypometabolism in the inferior parietal lobe and posterior cingulate/precuneus predicts progression from mild cognitive impairment (MCI) to AD dementia.
  • FDG PET may predict conversion from cognitively normal to MCI.
  • Age-related hypometabolism occurs in anterior cingulate and temporal lobes, often with atrophy.

Conclusions:

  • FDG PET is a valuable tool for differentiating dementia subtypes and predicting cognitive decline.
  • Statistical analysis methods improve the diagnostic accuracy of FDG PET in dementia.
  • Further research should explore the clinical and methodological potential of FDG PET in dementia.